An apology to Medarex CEO Howard Pien, 7 years in the making
Seven years ago, when I was a reporter covering the pharmaceutical industry for CBSNews.com, I became interested in a small company called Medarex. The company caught my eye because it was developing a drug for prostate cancer called ipilimumab.
from Biotech News
0 Comments